Stay updated on AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedA comprehensive Locations section listing multiple U.S. states and international regions has been added to the page. The page also shows a new Revision: v3.3.3 and the HHS Vulnerability Disclosure link has been removed.SummaryDifference1%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe update shows Revision: v3.3.2 replacing v3.3.1; no substantive study content or data on the page appears to be changed.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page shows a new revision entry Revision: v3.3.1 and removes Revision: v3.2.0, which is a minor update to the page's revision history and does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedRemoved the government funding status notice from the page; no study details, eligibility criteria, or enrollment data were changed. Access to study details, contacts, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe updates appear to modify only the Study Record Dates timestamps (e.g., Results First Posted, Results First Submitted, Last Update Posted); core study details, eligibility criteria, and outcome measures do not change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded concrete extension-study results, dosing regimens, participant eligibility, safety and efficacy endpoints, and results-reporting dates; removed some older, high-level extension details.SummaryDifference53%

Stay in the know with updates to AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVP-786 Long-Term Safety & Efficacy in Alzheimer's Agitation Clinical Trial page.